Great investors · John Paulson · Q2 2026
What John Paulson bought and sold in Q2 2026
Paulson & Co. 13F portfolio as of Jun 30, 2026: 8 positions worth $2.6 bn. Largest: MDGL, PPTA, AAMI, BHC. Filed with the SEC on Aug 14, 2026.
The 13F is filed by Paulson & Co., not by John Paulson personally: these are the whole firm's positions. A “position” is a distinct security in the filing (by CUSIP); share classes of the same company are shown added together.
Buys in Q2 2026
No purchase of 0.5 points of the portfolio or more this quarter.
Sells in Q2 2026
- Sold outAgnico Eagle MinesAEM−5.1 pp
- ReducedAcadian Asset ManagementAAMI−4.4 pp
- ReducedMadrigal PharmaceuticalsMDGL−0.9 pp
3 companies with material moves, out of 5 positions with a change. Only moves of 0.5 points of the portfolio or more are listed, measured as “traded weight” (what was bought or sold, excluding price effects). Smaller changes exist and are not listed: a position may have gone up or down without appearing above.
The full 13F, line by line
Paulson & Co.'s Q2 2026 13F lists 8 lines of US-listed securities worth $2.6 bn; the largest is MDGL at 27.9% of the portfolio. It was accepted by the SEC on Aug 14, 2026 at 4:58 PM ET.
Against the previous quarter, it opened 1 position (GOOGL), closed 1 (AEM), added to 1 (THM) and trimmed 2 (AAMI and MDGL). 4 lines show the same number of shares.
| # | Company | Shares | Value | Weight | Change in shares |
|---|---|---|---|---|---|
| 1 | Madrigal Pharmaceuticals MDGL | 1.3 M | $720M | 27.9% | −3.7% |
| 2 | Perpetua Resources PPTA | 32.3 M | $672M | 26.1% | no change |
| 3 | Acadian Asset Management AAMI | 5.8 M | $418M | 16.2% | −25% |
| 4 | Bausch Health Companies BHC | 73.3 M | $361M | 14.0% | no change |
| 5 | International Tower Hill Mines THM | 104.5 M | $208M | 8.07% | +4.9% |
| 6 | Novagold Resources NG | 27.2 M | $163M | 6.31% | no change |
| 7 | Thryv Holdings THRY | 8.4 M | $33.3M | 1.29% | no change |
| 8 | Alphabet GOOGL | 5,000 | $1.8M | 0.07% | new |
Positions it closed (1)
- Agnico Eagle Mines AEMwas 5.11% · 783,561 shares
One row per line of the filing (by CUSIP): share classes of the same company are listed separately here. “Change in shares” compares the count with the previous quarter, split-adjusted; the value is the one reported in the 13F at quarter end, not today's price.
Original documents: Paulson & Co.'s 13F filings on EDGAR (SEC) ↗
Follow John Paulson and see their Q3 2026 13F once it is filed
Free. We email you (if you turn it on) and in Following you see what each manager you follow bought and sold.
Source: 13F filings with the SEC. A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions. Not investment advice.